35 - Inhibition of the oncoprotein FUBP1 by SN-38 represents a novel therapeutic option for the treatment of hepatocellular carcinoma

Autor: Hauck, S., Khageh Hosseini, S., Wesely, J., Trojan, J., Gerlach, K., Schulze, J., Hahn, S., Steinhilber, D., Gatterdam, V., Zeuzem, S., Waidmann, O., Zangos, S., Biondi, R., Proschak, E., Zörnig, M.
Zdroj: In European Journal of Cancer December 2016 69 Supplement 1:S18-S18
Databáze: ScienceDirect